4//SEC Filing
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 4
Accession 0001209191-20-055033
CIK 0001741830other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 3:36 PM ET
Size
16.2 KB
Accession
0001209191-20-055033
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Transactions
- Conversion
Common Stock
2020-10-14$16.15/sh+185,758$2,999,992→ 4,274,996 total - Conversion
Series A Preferred Stock
2020-10-14−1,565,475→ 0 total→ Common Stock (1,651,576 underlying) - Conversion
Common Stock
2020-10-14+1,651,576→ 4,089,238 total - Conversion
Series Seed Preferred Stock
2020-10-14−300,001→ 0 total→ Common Stock (316,501 underlying) - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (185,758 underlying) - Conversion
Common Stock
2020-10-14+316,501→ 2,437,662 total - Purchase
Common Stock
2020-10-14$19.00/sh+95,500$1,814,500→ 4,370,496 total
Footnotes (2)
- [F1]Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001826661
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 3:36 PM ET
- Size
- 16.2 KB